Baird Medical Investment Holdings Ltd
BDMDdata completeness 100%4 fiscal years on filei. The business — what you’d actually own
| Figure | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|
| Revenue | $35.1M1 | $31.5M2 | $37M2 | $22.5M2 |
| Net income | $12.8M3 | $10.5M4 | $12.5M4 | −$27.3M4 |
| Operating cash flow | $485,9685 | −$1.02M6 | −$6.31M6 | −$1.34M6 |
| Capital expenditure | $5.91M7 | $2.64M8 | $2.85M8 | $42,3158 |
| Free cash flow (derived) | −$5.42M5 | −$3.66M6 | −$9.17M6 | −$1.39M6 |
| Total debt | — | $2.43M9 | $8.76M10 | $17.4M10 |
| Cash & equivalents | $1.71M11 | $1.51M11 | $2.97M12 | $178,32112 |
| Diluted shares | 25.6M | 20.6M | 21.8M | 27.8M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
ii. Your slice — ownership made literal
If you owned
shares
You’d own
0.000036%
of the whole company
Your share of last year’s profit
−$9.81
Your share of its debt
$6.28
Your share of free cash flow
−$0.5
iii. What it’s worth — engine v0.1.0
DCF · Growth Exit 10Y
not applicable
3y-median FCF non-positive — growth-exit DCF not applicable (see EPV)
DCF · Growth Exit 5Y
not applicable
3y-median FCF non-positive — growth-exit DCF not applicable (see EPV)
Earnings Power Value
$4.36
assumptions (8)
- riskFreeRate4.5%
- equityRiskPremium5.0%
- beta100.0%
- equityWeight85.0%
- costOfDebtSpread1.5%
- taxRate21.0%
- normalizedEarnings$11.5M
- growthAssumed0.0%
Graham Number
not applicable
diluted EPS missing or non-positive — Graham Number undefined
Different models answer different questions — which to trust when →
Sources — the receipts
- 20-F · period ending 2022-12-31 · accession 0001410578-25-001328 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 20-F · period ending 2023-12-31 · accession 0001104659-26-048641 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 20-F · period ending 2022-12-31 · accession 0001410578-25-001328 (ProfitLoss)
- 20-F · period ending 2023-12-31 · accession 0001104659-26-048641 (NetIncomeLoss)
- 20-F · period ending 2022-12-31 · accession 0001410578-25-001328 (NetCashProvidedByUsedInOperatingActivities)
- 20-F · period ending 2023-12-31 · accession 0001104659-26-048641 (NetCashProvidedByUsedInOperatingActivities)
- 20-F · period ending 2022-12-31 · accession 0001410578-25-001328 (PaymentsToAcquirePropertyPlantAndEquipment)
- 20-F · period ending 2023-12-31 · accession 0001104659-26-048641 (PaymentsToAcquirePropertyPlantAndEquipment)
- 20-F · period ending 2023-12-31 · accession 0001410578-25-001328 (LongTermDebtNoncurrent)
- 20-F · period ending 2024-12-31 · accession 0001104659-26-048641 (LongTermDebtNoncurrent)
- 20-F · period ending 2022-12-31 · accession 0001104659-26-048641 (CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents)
- 20-F · period ending 2024-12-31 · accession 0001104659-26-048641 (CashAndCashEquivalentsAtCarryingValue)